The ban on Chinese patent medicine in Britain has little influence on China

The UK drug administration has issued a warning to remind domestic consumers to be cautious about using some traditional Chinese medicines that have not been officially registered in the UK, and said it plans to ban the sale of Chinese patent medicines in the UK from the beginning of next year Liu Zhanglin, vice president of China Chamber of Commerce for the import and export of medical and health care products, said in an interview with the economic reference newspaper on the 9th that the UK ban has little impact on the export of Chinese patent medicine in China, because no Chinese patent medicine enterprise has registered its products in the UK so far It is reported that the above ban issued by the UK drug administration is based on the 2004 EU Directive on the registration procedure of traditional botanical drugs, which stipulates that the registration of Chinese patent medicines sold in the EU market must be completed on April 30, 2011, otherwise they are not allowed to be sold "The trend of drug export in the future is that drugs are drugs, health care products are health care products, and botanical drugs registered through the EU appear in the mainstream market of the EU in the form of drugs, which is the development trend But it is difficult to register now Although EU countries have also made simple procedures, it is still difficult for Chinese enterprises Since 2011, the grace period has been extended for another two years, but no enterprise has passed " Liu Zhanglin said Liu Zhanglin also pointed out that although the UK restricts the import of Chinese patent medicines, it does not restrict the entry of Chinese herbal pieces and formula granules into the market, so it has little impact on the export of Chinese herbal medicines to the EU.